Stories Library

We proudly offer support and resources to researchers, healthcare providers, patients and their advocates as well as our local communities.

Scientist holding test tube

January 25, 2023

Más genómica, menos miedo

By: Adolfo Ferrando, MD, PhD, Executive Director, Therapeutic Area Genetics, Oncology, Regeneron Genetics Center®

El genoma es el cómo y el por qué que nos define

Genetics, Research & Preclinical Development

Technical themed image of a test tube

January 25, 2023

More Genomics, Less Fear

By: Adolfo Ferrando, MD, PhD, Executive Director, Therapeutic Area Genetics, Oncology, Regeneron Genetics Center®

The genome is the how and why that define us

Genetics, Research & Preclinical Development

Graphic reading '1 in 700 PEOPLE have the rare loss-of-function CIDEB genetic mutation.'

October 03, 2022

Going “all in” with liver disease genetics

By: Luca A. Lotta, MD, PhD, Vice President, Head of Cardiometabolic and Musculoskeletal Disease Genetics

The "Team Science" approach leading to the discovery of CIDEB mutations that protect from liver disease

Genetics

RGC (REGENERON Genetic Center)

August 01, 2022

Experience Our Spectacular Science

At Regeneron, we continue to stay on the cutting edge as we build the medicines of tomorrow.

Technology

REGENERON Interns Group Photo

July 29, 2022

Defining Internship Experiences

By: Regina Thomas, Executive Director, Talent Acquisition

Nurturing the Next Generation of Scientific Innovators

Responsibility & Culture

3 volunteers of the Using Data For Good program

June 29, 2022

Using Data for Good

By: Potoula Stavropoulos, Senior Director, Social Impact 

Transformative impact through skills-based volunteering

Responsibility & Culture

A graphic showing the impact of high LDL-C levels in the wall of a blood vessel.

June 01, 2022

It Takes a Village

By: Viktoria (Vika) Gusarova, PhD, Senior Director, Obesity, Metabolism & Muscle Diseases
Sergio Fazio, MD, PhD, Scientific Council Chair, Cardiometabolic Diseases

Research that led to important discoveries for the treatment of dangerously high cholesterol

Research & Preclinical Development

A scientist storing supplies in a temperature controlled compartment

April 21, 2022

Striving for Impact through Responsibility

By: Christina Chan, Senior Vice President, Corporate Communications and Citizenship

Regeneron is committed to achieving our Global Responsibility Goals by 2025. Read the steps we're taking in the 2021 Responsibility Report.

Responsibility & Culture

3 women in discussion

December 21, 2021

Paving the Way for a Better Workplace, Better Science, and a Better World

By: Smita Pillai, Chief Diversity, Equity and Inclusion Officer

Regeneron’s first Chief Diversity, Equity & Inclusion (DEI) Officer, Smita Pillai, explains how leadership through action is ensuring our presence in biotech is mindful, equitable and intersectional.

Responsibility & Culture

Technician studying immunotherapy

November 09, 2021

Helping the several million immuno­compromised Americans who are still “Prisoners of the Pandemic”

By: George D. Yancopoulos, MD, PhD, Co-founder, President and Chief Scientific Officer of Regeneron

Regeneron has received numerous queries about making our REGEN-COV® (casirivimab and imdevimab) antibody cocktail available to protect immuno­compromised individuals who do not respond to COVID19 vaccines. This blog reflects our thinking and the current scientific evidence related to this question.

Responsibility & Culture